• The Haemophilia & Health Collective of North (HHCN) in collaboration with National Health Mission (NHM) representatives from 16 states have proposed guidelines for the treatment of Persons with Haemophilia (PwH) in India.
• The guidelines will address the “vaccum” that existed with respect to treatment and management of this rare disorder and consequently help both healthcare professionals and patients.
• HHCN is a registered body of India’s leading healthcare professionals working in the domain of haemophilia care for over two decades.

ABOUT HAEMOPHILIA

• Haemophilia is a rare and usually inherited bleeding disorder in which patients have a fault in a gene that regulates production of proteins called clotting factors.
• This disorder can lead to spontaneous bleeding as well as bleeding following injuries or surgery.
• Since the gene is carried on the X chromosome, hemophilia is almost entirely a male disease.
• Types-
  • The most common type of Haemophilia is called Haemophilia A where the person does not have enough clotting factor 8.
    • Haemophilia A, occurs in about 1 in 5,000 births.
  • In Haemophilia B, person lacks enough factor 9.
    • Haemophilia B is even rarer at about 1 in about 20,000 births.
  • Haemophilia C, also known as Rosenthal syndrome occurs due to the deficiency of factor 11.